Farmacia
Fakultatea
Pfizer (United States)
Nueva York, Estados UnidosPfizer (United States)-ko ikertzaileekin lankidetzan egindako argitalpenak (14)
2024
-
Antibiotic resistance and tolerance: What can drug delivery do against this global threat?
Drug Delivery and Translational Research, Vol. 14, Núm. 6, pp. 1725-1734
2023
-
Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity
Cell, Vol. 186, Núm. 12, pp. 2628-2643.e21
2021
-
Estimating the annual economic burden for the management of patients with transthyretin amyloid polyneuropathy in Spain
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 21, Núm. 5, pp. 967-973
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2020
-
Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain
Clinical Rheumatology, Vol. 39, Núm. 10, pp. 2919-2930
2019
-
Burden of diabetes mellitus in patients with acromegaly treated with second-line pharmacotherapy in Spain
ClinicoEconomics and Outcomes Research, Vol. 11, pp. 465-475
2016
2009
-
A global benchmark study using affinity-based biosensors
Analytical Biochemistry, Vol. 386, Núm. 2, pp. 194-216
2008
-
Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and surveillance trial
Clinical Microbiology and Infection, Vol. 14, Núm. 4, pp. 307-314
2006
-
Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: Potential implications for plaque stabilization
Journal of Cardiovascular Pharmacology, Vol. 47, Núm. 1, pp. 60-69
2005
-
HMG-CoA reductase inhibitors reduce IκB kinase activity induced by oxidative stress in monocytes and vascular smooth muscle cells
Journal of Cardiovascular Pharmacology, Vol. 45, Núm. 5, pp. 468-475
-
Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month
Stroke, Vol. 36, Núm. 8, pp. 1796-1800
2002
-
Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells
Atherosclerosis, Vol. 160, Núm. 1, pp. 49-58